Title
Virulence factors profiles and ESBL production in Escherichia coli causing bacteremia in Peruvian children
Date Issued
01 September 2016
Access level
metadata only access
Resource Type
journal article
Author(s)
Centro de Investigación en Salud Internacional de Barcelona
Centro de Investigación en Salud Internacional de Barcelona
Publisher(s)
Elsevier Inc.
Abstract
The presence of 25 virulence genes (VGs), genetic phylogroups, quinolone-resistance and Extended Spectrum β-lactamase (ESBL)-production was assessed in 65 Escherichia coli isolates from blood cultures in children <5 years in Peru. The most frequent VGs were fimA (89.2%), iutA (83.1%), agn43 (72.3%), iucA (67.7%), and fyuA (49.2%). The isolates belonged to D (47.7%), A (26.1%), B1 (21.5%), and B2 (4.6%) phylogroups. D + B2 isolates presented a high number of fimA, hly, papC, sat, and fyuA genes. Quinolone-susceptible (22 isolates – 33.8%) and ESBL-negative (31 isolates – 47.7%) isolates carried more VGs that their respective counterparts (5.7 vs. 4.7 and 5.3 vs. 4.4 respectively); the frequency of the fyuA, aat, aap, and hly genes significantly differed between quinolone-resistant and quinolone-susceptible isolates. Neonatal sepsis isolates tended to be more quinolone-resistant (P = 0.0697) and ESBL-producers (P = 0.0776). Early-onset neonatal sepsis isolates possessed a high number of VGs (5.2 VGs), especially in neonates of ≤1 day (5.9 VGs).
Start page
70
End page
75
Volume
86
Issue
1
Language
English
OCDE Knowledge area
Virología Pediatría
Publication version
Version of Record
Scopus EID
2-s2.0-84977555553
PubMed ID
Source
Diagnostic Microbiology and Infectious Disease
ISSN of the container
07328893
Sponsor(s)
JR has a fellowship from the program I3SNS of the ISCIII (grant number: CES11/012), and CG has a predoctoral grant from the ISCIII (FI12/00561). This work was supported by Agencia Española de Cooperación Internacional para el Desarrollo (AECID), Spain, Programa de Cooperación Interuniversitaria e Investigación Científica con Iberoamérica (D/019499/08, D/024648/09, D/030509/10, and A1/035720/11) (J.R and T.J.O) by the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015) and Generalitat de Catalunya, Departament d’Universitats, Recerca i Societat de la Informació (2014 SGR 26) (JR) and Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 3, project 95502).
Sources of information: Directorio de Producción Científica Scopus